198 related articles for article (PubMed ID: 3508715)
1. Two modes of action of bisphosphonates on osteoclastic resorption of mineralized matrix.
Boonekamp PM; van der Wee-Pals LJ; van Wijk-van Lennep MM; Thesing CW; Bijvoet OL
Bone Miner; 1986 Feb; 1(1):27-39. PubMed ID: 3508715
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of the inhibitory action of APD on the transformation of osteoclast precursors into resorbing cells after dimethylation of the amino group.
Boonekamp PM; Löwik CW; van der Wee-Pals LJ; van Wijk-van Lennep ML; Bijvoet OL
Bone Miner; 1987 Feb; 2(1):29-42. PubMed ID: 3504722
[TBL] [Abstract][Full Text] [Related]
3. Bisphosphonates suppress bone resorption by a direct effect on early osteoclast precursors without affecting the osteoclastogenic capacity of osteogenic cells: the role of protein geranylgeranylation in the action of nitrogen-containing bisphosphonates on osteoclast precursors.
Van Beek ER; Löwik CW; Papapoulos SE
Bone; 2002 Jan; 30(1):64-70. PubMed ID: 11792566
[TBL] [Abstract][Full Text] [Related]
4. Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro.
Carano A; Teitelbaum SL; Konsek JD; Schlesinger PH; Blair HC
J Clin Invest; 1990 Feb; 85(2):456-61. PubMed ID: 2105340
[TBL] [Abstract][Full Text] [Related]
5. Differential action of the bisphosphonates (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD) and disodium dichloromethylidene bisphosphonate (Cl2MDP) on rat macrophage-mediated bone resorption in vitro.
Reitsma PH; Teitelbaum SL; Bijvoet OL; Kahn AJ
J Clin Invest; 1982 Nov; 70(5):927-33. PubMed ID: 7130396
[TBL] [Abstract][Full Text] [Related]
6. Migration and phenotypic transformation of osteoclast precursors into mature osteoclasts: the effect of a bisphosphonate.
Löwik CW; van der Pluijm G; van der Wee-Pals LJ; van Treslong-De Groot HB; Bijvoet OL
J Bone Miner Res; 1988 Apr; 3(2):185-92. PubMed ID: 3213614
[TBL] [Abstract][Full Text] [Related]
7. Effects of bisphosphonates on isolated rat osteoclasts as examined by reflected light microscopy.
Sato M; Grasser W
J Bone Miner Res; 1990 Jan; 5(1):31-40. PubMed ID: 2106763
[TBL] [Abstract][Full Text] [Related]
8. Interaction between effects of parathyroid hormone and bisphosphonate on regulation of osteoclast activity by the osteoblast-like cell line UMR-106.
Yu X; Schøller J; Foged NT
Bone; 1996 Oct; 19(4):339-45. PubMed ID: 8894139
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of bone matrix apposition by (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (AHPrBP) in the mouse.
Marie PJ; Hott M; Garba MT
Bone; 1985; 6(3):193-200. PubMed ID: 4027097
[TBL] [Abstract][Full Text] [Related]
10. Bisphosphonates act on rat bone resorption through the mediation of osteoblasts.
Sahni M; Guenther HL; Fleisch H; Collin P; Martin TJ
J Clin Invest; 1993 May; 91(5):2004-11. PubMed ID: 8486770
[TBL] [Abstract][Full Text] [Related]
11. Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone.
Flanagan AM; Chambers TJ
Bone Miner; 1989 Apr; 6(1):33-43. PubMed ID: 2526673
[TBL] [Abstract][Full Text] [Related]
12. The bisphosphonate tiludronate is a potent inhibitor of the osteoclast vacuolar H(+)-ATPase.
David P; Nguyen H; Barbier A; Baron R
J Bone Miner Res; 1996 Oct; 11(10):1498-507. PubMed ID: 8889850
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone.
Flanagan AM; Chambers TJ
Calcif Tissue Int; 1991 Dec; 49(6):407-15. PubMed ID: 1840176
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates can reduce osteoclastic bone resorption by two different mechanisms.
Löwik CW; Boonekamp PM; van de Pluym G; van de Wee-Pals L; Bloys van Treslong-de Groot H; Bijvoet OL
Adv Exp Med Biol; 1986; 208():275-81. PubMed ID: 2951984
[No Abstract] [Full Text] [Related]
15. Effects of two novel bisphosphonates on bone cells in vitro.
Evans CE; Braidman IP
Bone Miner; 1994 Aug; 26(2):95-107. PubMed ID: 7994190
[TBL] [Abstract][Full Text] [Related]
16. Effect of dichloromethylene diphosphonate on bone metabolism in calcium and phosphorus-depleted rats.
Evans RA; Wergedal JE; Baylink DJ
Miner Electrolyte Metab; 1983; 9(3):119-24. PubMed ID: 6224075
[TBL] [Abstract][Full Text] [Related]
17. Effects of four bisphosphonates on bone resorption, lysosomal enzyme release, protein synthesis and mitotic activities in mouse calvarial bones in vitro.
Lerner UH; Larsson A
Bone; 1987; 8(3):179-89. PubMed ID: 2955802
[TBL] [Abstract][Full Text] [Related]
18. Modulation of PTH-stimulated osteoclastic resorption by bisphosphonates in fetal mouse bone explants.
van der Pluijm G; Löwik CW; de Groot H; Alblas MJ; van der Wee-Pals LJ; Bijvoet OL; Papapoulos SE
J Bone Miner Res; 1991 Nov; 6(11):1203-10. PubMed ID: 1839590
[TBL] [Abstract][Full Text] [Related]
19. Current topics in pharmacological research on bone metabolism: inhibitory effects of bisphosphonates on the differentiation and activity of osteoclasts.
Suzuki K; Takeyama S; Sakai Y; Yamada S; Shinoda H
J Pharmacol Sci; 2006 Mar; 100(3):189-94. PubMed ID: 16518076
[TBL] [Abstract][Full Text] [Related]
20. Two distinct effects of recombinant human tumor necrosis factor-alpha on osteoclast development and subsequent resorption of mineralized matrix.
van der Pluijm G; Most W; van der Wee-Pals L; de Groot H; Papapoulos S; Löwik C
Endocrinology; 1991 Sep; 129(3):1596-604. PubMed ID: 1874190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
